Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.

Infection of the developing fetus with human cytomegalovirus (HCMV) is a major cause of central nervous system disease in infants and children; however, mechanism(s) of disease associated with this intrauterine infection remain poorly understood. Utilizing a mouse model of HCMV infection of the deve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kate Kosmac, Glenn R Bantug, Ester P Pugel, Djurdjica Cekinovic, Stipan Jonjic, William J Britt
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Acceso en línea:https://doaj.org/article/1c7cd2f8965641fd8bb1acdc18fc03b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c7cd2f8965641fd8bb1acdc18fc03b1
record_format dspace
spelling oai:doaj.org-article:1c7cd2f8965641fd8bb1acdc18fc03b12021-11-18T06:05:57ZGlucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.1553-73661553-737410.1371/journal.ppat.1003200https://doaj.org/article/1c7cd2f8965641fd8bb1acdc18fc03b12013-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23505367/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Infection of the developing fetus with human cytomegalovirus (HCMV) is a major cause of central nervous system disease in infants and children; however, mechanism(s) of disease associated with this intrauterine infection remain poorly understood. Utilizing a mouse model of HCMV infection of the developing CNS, we have shown that peripheral inoculation of newborn mice with murine CMV (MCMV) results in CNS infection and developmental abnormalities that recapitulate key features of the human infection. In this model, animals exhibit decreased granule neuron precursor cell (GNPC) proliferation and altered morphogenesis of the cerebellar cortex. Deficits in cerebellar cortical development are symmetric and global even though infection of the CNS results in a non-necrotizing encephalitis characterized by widely scattered foci of virus-infected cells with mononuclear cell infiltrates. These findings suggested that inflammation induced by MCMV infection could underlie deficits in CNS development. We investigated the contribution of host inflammatory responses to abnormal cerebellar development by modulating inflammatory responses in infected mice with glucocorticoids. Treatment of infected animals with glucocorticoids decreased activation of CNS mononuclear cells and expression of inflammatory cytokines (TNF-α, IFN-β and IFNγ) in the CNS while minimally impacting CNS virus replication. Glucocorticoid treatment also limited morphogenic abnormalities and normalized the expression of developmentally regulated genes within the cerebellum. Importantly, GNPC proliferation deficits were normalized in MCMV infected mice following glucocorticoid treatment. Our findings argue that host inflammatory responses to MCMV infection contribute to deficits in CNS development in MCMV infected mice and suggest that similar mechanisms of disease could be responsible for the abnormal CNS development in human infants infected in-utero with HCMV.Kate KosmacGlenn R BantugEster P PugelDjurdjica CekinovicStipan JonjicWilliam J BrittPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 9, Iss 3, p e1003200 (2013)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Kate Kosmac
Glenn R Bantug
Ester P Pugel
Djurdjica Cekinovic
Stipan Jonjic
William J Britt
Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
description Infection of the developing fetus with human cytomegalovirus (HCMV) is a major cause of central nervous system disease in infants and children; however, mechanism(s) of disease associated with this intrauterine infection remain poorly understood. Utilizing a mouse model of HCMV infection of the developing CNS, we have shown that peripheral inoculation of newborn mice with murine CMV (MCMV) results in CNS infection and developmental abnormalities that recapitulate key features of the human infection. In this model, animals exhibit decreased granule neuron precursor cell (GNPC) proliferation and altered morphogenesis of the cerebellar cortex. Deficits in cerebellar cortical development are symmetric and global even though infection of the CNS results in a non-necrotizing encephalitis characterized by widely scattered foci of virus-infected cells with mononuclear cell infiltrates. These findings suggested that inflammation induced by MCMV infection could underlie deficits in CNS development. We investigated the contribution of host inflammatory responses to abnormal cerebellar development by modulating inflammatory responses in infected mice with glucocorticoids. Treatment of infected animals with glucocorticoids decreased activation of CNS mononuclear cells and expression of inflammatory cytokines (TNF-α, IFN-β and IFNγ) in the CNS while minimally impacting CNS virus replication. Glucocorticoid treatment also limited morphogenic abnormalities and normalized the expression of developmentally regulated genes within the cerebellum. Importantly, GNPC proliferation deficits were normalized in MCMV infected mice following glucocorticoid treatment. Our findings argue that host inflammatory responses to MCMV infection contribute to deficits in CNS development in MCMV infected mice and suggest that similar mechanisms of disease could be responsible for the abnormal CNS development in human infants infected in-utero with HCMV.
format article
author Kate Kosmac
Glenn R Bantug
Ester P Pugel
Djurdjica Cekinovic
Stipan Jonjic
William J Britt
author_facet Kate Kosmac
Glenn R Bantug
Ester P Pugel
Djurdjica Cekinovic
Stipan Jonjic
William J Britt
author_sort Kate Kosmac
title Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
title_short Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
title_full Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
title_fullStr Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
title_full_unstemmed Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
title_sort glucocorticoid treatment of mcmv infected newborn mice attenuates cns inflammation and limits deficits in cerebellar development.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/1c7cd2f8965641fd8bb1acdc18fc03b1
work_keys_str_mv AT katekosmac glucocorticoidtreatmentofmcmvinfectednewbornmiceattenuatescnsinflammationandlimitsdeficitsincerebellardevelopment
AT glennrbantug glucocorticoidtreatmentofmcmvinfectednewbornmiceattenuatescnsinflammationandlimitsdeficitsincerebellardevelopment
AT esterppugel glucocorticoidtreatmentofmcmvinfectednewbornmiceattenuatescnsinflammationandlimitsdeficitsincerebellardevelopment
AT djurdjicacekinovic glucocorticoidtreatmentofmcmvinfectednewbornmiceattenuatescnsinflammationandlimitsdeficitsincerebellardevelopment
AT stipanjonjic glucocorticoidtreatmentofmcmvinfectednewbornmiceattenuatescnsinflammationandlimitsdeficitsincerebellardevelopment
AT williamjbritt glucocorticoidtreatmentofmcmvinfectednewbornmiceattenuatescnsinflammationandlimitsdeficitsincerebellardevelopment
_version_ 1718424587868307456